Dabigatran discontinuation in "real-world" practice among Chinese population

被引：0
|
作者：
Ho, M. H. [1 ]
Cheung, E. [1 ]
Ho, C. W. [1 ]
Tse, H. F. [1 ]
Siu, C. W. [1 ]
机构：
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6232
引用
收藏
页码：1104 / 1104
页数：1
相关论文
共 50 条
  • [1] Continuation of Dabigatran Therapy in "Real-World" Practice in Hong Kong
    Ho, Mei Han
    Ho, Chi Wai
    Cheung, Emmanuel
    Chan, Pak Hei
    Hai, Jo Jo
    Chan, Koon Ho
    Chan, Esther W.
    Leung, Gilberto Ka Kit
    Tse, Hung Fat
    Siu, Chung Wah
    PLOS ONE, 2014, 9 (08):
  • [2] Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice
    Hwang, Jongmin
    Lee, So-Ryoung
    Park, Hyoung-Seob
    Lee, Young Soo
    Ahn, Jin Hee
    Choi, Jong-Il
    Shin, Dong Gu
    Kim, Dae-Kyeong
    Park, Jong Sung
    Hwang, Ki Won
    Cha, Tae-Joon
    Choi, Eue-Keun
    Han, Seongwook
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 323 : 77 - 82
  • [3] SAFETY AND EFFECTIVENESS OF DABIGATRAN IN ATRIAL FIBRILLATION IN A REAL-WORLD POPULATION
    Pichette, M.
    Dutilleul, A.
    Stevens, L.
    Noiseux, N.
    Gobeil, F.
    Mansour, S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S103 - S103
  • [4] Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
    Lip, Gregory Y. H.
    Pan, Xianying
    Kamble, Shital
    Kawabata, Hugh
    Mardekian, Jack
    Masseria, Cristina
    Phatak, Hemant
    PLOS ONE, 2018, 13 (04):
  • [5] Real-world experience with reversal of dabigatran by idarucizumab
    Haastrup, Simone Bonde
    Hellfritzsch, Maja
    Nybo, Mads
    Hvas, Anne-Mette
    Grove, Erik Lerkevang
    THROMBOSIS RESEARCH, 2021, 197 : 179 - 184
  • [6] Persistence, effectiveness and safety of dabigatran in “real-world” Chinese patients with nonvalvular atrial fibrillation
    Guodong Rong
    Yiling Huang
    Lin Wang
    Hanyu Liang
    Hong Wang
    Heart and Vessels, 2020, 35 : 977 - 984
  • [7] Real-world practice
    Corboy, John R.
    NEUROLOGY-CLINICAL PRACTICE, 2018, 8 (04) : 275 - 275
  • [8] Persistence, effectiveness and safety of dabigatran in "real-world" Chinese patients with nonvalvular atrial fibrillation
    Rong, Guodong
    Huang, Yiling
    Wang, Lin
    Liang, Hanyu
    Wang, Hong
    HEART AND VESSELS, 2020, 35 (07) : 977 - 984
  • [9] Natalizumab discontinuation in a dutch real-world cohort
    Coerver, E.
    Wessels, M.
    Van Lierop, Z.
    Van Kempen, Z.
    Killestein, J.
    Strijbis, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 347 - 348
  • [10] Natalizumab discontinuation in a Dutch real-world cohort
    Coerver, E. M. E.
    Wessels, M. H. J.
    van Lierop, Z. Y. G.
    van Kempen, Z. L. E.
    Killestein, J.
    Strijbis, E. M. M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
12345